Undisclosed Collaborative Program 3

About D.E. Shaw Research

D.E. Shaw Research is a private, computationally-driven drug discovery company that operates at the intersection of supercomputing, molecular dynamics, and machine learning. The company has built a unique, fully integrated platform combining proprietary hardware (Anton supercomputers) and software to simulate biological processes with unprecedented timescales and resolution. This enables the atomic-level design of novel therapeutics, resulting in a pipeline with seven clinical-stage drug candidates, three of which were designed independently. The company represents a highly specialized and capital-intensive approach to de-risking early-stage drug discovery through physics-based simulation.

Other Undisclosed Drugs